Benzinga | Aug 19, 2021 04:09PM EDT

Immunome Q2 EPS $(0.46) Misses $(0.39) Estimate

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.39) by 17.95 percent.